Clinical Trial Detail

NCT ID NCT02344810
Title C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Eastern Cooperative Oncology Group
Indications

esophageal carcinoma

gastrointestinal system cancer

gastroesophageal junction adenocarcinoma

stomach carcinoma

Therapies

AMG 337

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult

Additional content available in CKB BOOST